Suchergebnisse - "Zarakowska, Ewelina"

PubPharm (6)

1

Context dependent effects of ascorbic acid treatment in TET2 mutant myeloid neoplasia

enthalten in: Communications biology | 2020

von Guan, Y. | Greenberg, E. | Hasipek, M. | +18

2

5-formylcytosine and 5-hydroxymethyluracil as surrogate markers of TET2 and SF3B1 mutations in myelodysplastic syndrome, respectively

enthalten in: Haematologica | 2020

von Gackowski, D. | Gawronski, M. | Kerr, C. | +7

3

In vivo evidence of ascorbate involvement in the generation of epigenetic DNA modifications in leukocytes from patients with colorectal carcinoma, benign adenoma and inflammatory bowel disease

enthalten in: Journal of translational medicine | 2018

von Starczak, M. | Zarakowska, E. | Modrzejewska, M. | +13

4

Characteristic profiles of DNA epigenetic modifications in colon cancer and its predisposing conditions-benign adenomas and inflammatory bowel disease

enthalten in: Clinical epigenetics | 2018

von Dziaman, T. | Gackowski, D. | Guz, J. | +15

5

Vitamin C enhances substantially formation of 5-hydroxymethyluracil in cellular DNA

enthalten in: Free radical biology & medicine | 2016

von Modrzejewska, M. | Gawronski, M. | Skonieczna, M. | +6

6

Are 8-oxoguanine (8-oxoGua) and 5-hydroxymethyluracil (5-hmUra) oxidatively damaged DNA bases or transcription (epigenetic) marks?

enthalten in: Mutation research. Genetic toxicology and environmental mutagenesis | 2014

von Zarakowska, E. | Gackowski, D. | Foksinski, M. | +1

1
[1]